The emerging role of radioimmunotherapy in haematological malignancies.
about
Antibody therapy of lymphoma.In vivo molecular targeted radiotherapy.Monoclonal antibody therapy of B cell lymphoma.Targeted alpha-therapy for control of micrometastatic prostate cancer.New insights into the mechanisms of action of radioimmunotherapy in lymphoma.Rituximab and other emerging monoclonal antibody therapies for lymphoma.
P2860
The emerging role of radioimmunotherapy in haematological malignancies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The emerging role of radioimmunotherapy in haematological malignancies.
@ast
The emerging role of radioimmunotherapy in haematological malignancies.
@en
type
label
The emerging role of radioimmunotherapy in haematological malignancies.
@ast
The emerging role of radioimmunotherapy in haematological malignancies.
@en
prefLabel
The emerging role of radioimmunotherapy in haematological malignancies.
@ast
The emerging role of radioimmunotherapy in haematological malignancies.
@en
P2860
P1476
The emerging role of radioimmunotherapy in haematological malignancies.
@en
P2093
Illidge TM
Johnson PW
P2860
P304
P356
10.1046/J.1365-2141.2000.01926.X
P407
P577
2000-03-01T00:00:00Z